Hematology (all articles)
[Abstract Only] Observational Study Suggests Apixaban May Be a Better Choice than Rivaroxaban for Patients with Atrial Fibrillation
11 Mar, 2020 | 08:20h | UTCEffectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban – TCTMD (free)
[Abstract Only] Study: Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
28 Feb, 2020 | 08:18h | UTCMicrobiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Higher Microbiota Diversity in Hematologic Cancer Treatment Could Lower Mortality Risk, Study Finds – AJMC (free) AND Gut Diversity Before HCT Predicts Survival in Blood Cancers – MedPage Today (free registration required)
[Abstract Only] Meta-Analysis of Observational Studies Suggests No Benefit from Oral Anticoagulation in Patients With Atrial Fibrillation on Long-Term Dialysis
26 Feb, 2020 | 07:00h | UTCOral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Anticoagulation for Dialysis Patients with Atrial Fibrillation: No Benefit Seen – NEJM Journal Watch (free for a limited period)
[Abstract Only] Meta-Analysis: Lower vs. Standard INR Targets in Atrial Fibrillation
25 Feb, 2020 | 06:04h | UTCLower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Thrombosis and Haemostasis (link to abstract – $ for full-text)
Source: EvidenceAlerts
[Not Published Yet] Randomized Trial: Improved Outcomes with Myeloablative Therapy Compared to Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
23 Feb, 2020 | 21:17h | UTCMyeloablative Therapy Prevails in AML Transplant Study – MedPage Today (free registration required)
Original Report: Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes – Journal of Clinical Oncology (free)
[Abstract Only] Meta-Analysis: Clinical Pre‐test Probability Adjusted vs. Age‐adjusted D‐dimer Interpretation Strategy for DVT Diagnosis
20 Feb, 2020 | 08:36h | UTCClinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis – Journal of Thrombosis and Haemostasis (link to abstract – $ for full-text)
Commentary: Clinical Pre-test Prob vs. Age-adjusted D-dimer for DVT – The Meta Analysis – JournalFeed (free)
Related Studies: Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability – New England Journal of Medicine (link to abstract and commentary) AND Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study – JAMA (free)
Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with BCL-2 Inhibitors: Risk Factors, Prophylaxis, and Treatment Recommendations
18 Feb, 2020 | 08:04h | UTCTumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations – The Lancet Haematology (free registration required)
Immunization Strategies to Span the Spectrum of Immunocompromised Adults
16 Feb, 2020 | 20:43h | UTCImmunization Strategies to Span the Spectrum of Immunocompromised Adults – Mayo Clinic Proceedings (free)
Study: Lower GI-bleeding in Anticoagulated Patients with Atrial Fibrillation Should Always Raise Suspicion of Colorectal Cancer
9 Feb, 2020 | 20:47h | UTCCommentary: GI Bleeding and Colorectal Cancer Risk in Anticoagulated AF Patients – American College of Cardiology (free) AND GI bleeding often mistaken as side effect of blood thinners when it could indicate cancer – Cardiovascular Business (free)
Review: How I Treat Cancer-associated Thrombosis
9 Feb, 2020 | 20:18h | UTCHow I treat cancer-associated thrombosis – ESMO Open (free)
Related: ASCO Guideline: Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer (free)
European Consensus Recommendation: Prophylaxis and Management of GVHD after Stem-cell Transplantation for Hematological Malignancies
2 Feb, 2020 | 19:51h | UTCProphylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation – The Lancet Haematology (free registration required)
A Network Meta-analysis of Maintenance Therapy in Chronic Lymphocytic Leukemia
31 Jan, 2020 | 00:54h | UTCA network meta-analysis of maintenance therapy in chronic lymphocytic leukemia – PLOS One (free)
BSH Guideline: Laboratory Diagnosis of G6PD Deficiency
30 Jan, 2020 | 07:36h | UTC
Sickle Cell Disease: A Primary Care Update
30 Jan, 2020 | 07:32h | UTCSickle cell disease: A primary care update – Cleveland Clinic Journal of Medicine (free)
ASH Guidelines for Sickle Cell Disease: Transfusion Support
29 Jan, 2020 | 08:27h | UTC
Meta-Analysis of Direct Oral Anticoagulants Randomized Trials: Double vs. Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention
22 Jan, 2020 | 09:28h | UTCRelated: Meta-analysis: Double Anti-thrombotic Therapy Safer than Triple Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease (studies on the subject)
[Abstract Only] Randomized Trial: Effects of Addition of Anti-thymocyte Globulin to Standard Graft-versus-host Disease Prophylaxis in Patients with Hematological Malignancies Undergoing Transplantation from Unrelated Donor
22 Jan, 2020 | 09:16h | UTCAddition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial – The Lancet Haematology (link to abstract – $ for full-text)
Recommendations for Therapeutic Apheresis
21 Jan, 2020 | 01:10h | UTC
Addendum to BSH Guidelines on Investigation and Management of Antiphospholipid Syndrome: Use of Direct Acting Oral Anticoagulants
19 Jan, 2020 | 20:55h | UTCRelated: Randomized Trial: DOAC Not as Good as Vitamin K Antagonist for Anticoagulation in Antiphospholipid Syndrome (link to abstract and commentaries)
Cohort Study: Incidental Lymphopenia and Mortality
19 Jan, 2020 | 20:45h | UTCCommentaries: Lymphopenia may hint a higher risk of future illness, death – News Medical (free) AND Incidental Low Lymphocyte Count Linked to Increased Mortality – MedicalResearch.com (free)
Randomized Trial: Effect of Dasatinib vs. Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
19 Jan, 2020 | 20:38h | UTCEffect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary: Dasatinib Superior to Imatinib in Pediatric ALL – MedPage Today (free)
Randomized Trial: Twice-daily vs. Alternate-day Oral Iron Therapy in the Treatment of Iron-deficiency Anemia
16 Jan, 2020 | 03:23h | UTC
Review: Surveillance in Patients with Diffuse Large B Cell Lymphoma
15 Jan, 2020 | 01:07h | UTCSurveillance in Patients with Diffuse Large B Cell Lymphoma – Mayo Clinic Proceedings (free)
Meta-Analysis: Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults with Transplant‐Ineligible Multiple Myeloma
15 Jan, 2020 | 00:54h | UTCMultiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis – Cochrane Library (free)
Commentary: Featured Review: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma – Cochrane Library (free)
ESMO Guideline: Marginal Zone Lymphomas
14 Jan, 2020 | 00:26h | UTC